Segments and Geographic Information - Sales by Product Category (Details) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
|
May 31, 2025
USD ($)
|
May 31, 2024
USD ($)
|
May 31, 2023
USD ($)
|
|
| Segment Reporting Information [Line Items] | |||
| Net sales | $ 292,498 | $ 303,914 | $ 338,752 |
| Cost of sales (exclusive of intangible amortization) | 134,793 | 149,216 | 164,506 |
| Gross margin | $ 157,705 | $ 154,698 | $ 174,246 |
| Gross Margin % | 0.539 | 0.509 | 0.514 |
| Operating Expenses | $ 197,659 | $ 401,632 | $ 225,427 |
| Gain on sale of assets | 0 | 54,499 | 0 |
| Total other income (expense), net | 5,922 | 797 | (3,256) |
| Loss before income tax benefit | (34,032) | (191,638) | (54,437) |
| Med Tech | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | 126,653 | 106,403 | 96,687 |
| Cost of sales (exclusive of intangible amortization) | 48,138 | 39,205 | 34,721 |
| Gross margin | $ 78,515 | $ 67,198 | $ 61,966 |
| Gross Margin % | 0.620 | 0.632 | 0.641 |
| Med Device | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | $ 165,845 | $ 197,511 | $ 242,065 |
| Cost of sales (exclusive of intangible amortization) | 86,655 | 110,011 | 129,785 |
| Gross margin | $ 79,190 | $ 87,500 | $ 112,280 |
| Gross Margin % | 0.477 | 0.443 | 0.464 |
| Med Tech | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | $ 126,653 | $ 106,403 | $ 96,687 |
| Med Device | |||
| Segment Reporting Information [Line Items] | |||
| Net sales | $ 165,845 | $ 197,511 | $ 242,065 |
| X | ||||||||||
- Definition Gross Margin, Percentage No definition available.
|
| X | ||||||||||
- Definition Other Nonoperating Income (Expense) And Interest Expense No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|